These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15262303)

  • 1. Medical therapies for non-melanoma skin cancer.
    Chakrabarty A; Geisse JK
    Clin Dermatol; 2004; 22(3):183-8. PubMed ID: 15262303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel medical strategies combating nonmelanoma skin cancer.
    Bhandari PR; Pai VV
    Indian J Dermatol; 2014 Nov; 59(6):531-46. PubMed ID: 25484380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonsurgical treatment of nonmelanoma skin cancer in the mature patient.
    Čeović R; Petković M; Mokos ZB; Kostović K
    Clin Dermatol; 2018; 36(2):177-187. PubMed ID: 29566922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical therapy for actinic keratoses, I: 5-Fluorouracil and imiquimod.
    Tutrone WD; Saini R; Caglar S; Weinberg JM; Crespo J
    Cutis; 2003 May; 71(5):365-70. PubMed ID: 12769403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basic pharmacology of topical imiquimod, 5-fluorouracil, and diclofenac for the dermatologic surgeon.
    Desai T; Chen CL; Desai A; Kirby W
    Dermatol Surg; 2012 Jan; 38(1):97-103. PubMed ID: 22092926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance of Nonmelanoma Skin Cancer to Nonsurgical Treatments. Part I: Topical Treatments.
    Gracia-Cazaña T; González S; Gilaberte Y
    Actas Dermosifiliogr; 2016 Nov; 107(9):730-739. PubMed ID: 27436800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy of basal cell carcinoma: evolving approaches.
    Gaspari AA; Sauder DN
    Dermatol Surg; 2003 Oct; 29(10):1027-34. PubMed ID: 12974699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical approaches to non-melanoma skin cancer.
    Micali G; Lacarrubba F; Bhatt K; Nasca MR
    Expert Rev Anticancer Ther; 2013 Dec; 13(12):1409-21. PubMed ID: 24236820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imiquimod and superficial skin cancers.
    Naylor M
    J Drugs Dermatol; 2005; 4(5):598-606. PubMed ID: 16167419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intralesional 5-fluorouracil (FU) as a treatment for nonmelanoma skin cancer (NMSC): A review.
    Metterle L; Nelson C; Patel N
    J Am Acad Dermatol; 2016 Mar; 74(3):552-7. PubMed ID: 26577512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total body topical 5-fluorouracil for extensive non-melanoma skin cancer.
    van Ruth S; Jansman FG; Sanders CJ
    Pharm World Sci; 2006 Jun; 28(3):159-62. PubMed ID: 17004017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential role of molecularly targeted therapy in the management of advanced nonsmall cell lung carcinoma in the elderly.
    Gridelli C; Massarelli E; Maione P; Rossi A; Herbst RS; Onn A; Ciardiello F
    Cancer; 2004 Oct; 101(8):1733-44. PubMed ID: 15386339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of nonmelanoma skin cancer in 2007.
    Neville JA; Welch E; Leffell DJ
    Nat Clin Pract Oncol; 2007 Aug; 4(8):462-9. PubMed ID: 17657251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COX-2 inhibitors as radiation sensitizers for upper GI tract cancers: esophagus, stomach, and pancreas.
    Rich TA; Shepard R
    Am J Clin Oncol; 2003 Aug; 26(4):S110-3. PubMed ID: 12902867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COX-2 inhibitor as a radiation enhancer: new strategies for the treatment of lung cancer.
    Saha D; Pyo H; Choy H
    Am J Clin Oncol; 2003 Aug; 26(4):S70-4. PubMed ID: 12902860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical therapies for skin cancer and actinic keratosis.
    Haque T; Rahman KM; Thurston DE; Hadgraft J; Lane ME
    Eur J Pharm Sci; 2015 Sep; 77():279-89. PubMed ID: 26091570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential role of selective COX-2 inhibitors in cancer management.
    Dang CT; Shapiro CL; Hudis CA
    Oncology (Williston Park); 2002 May; 16(5 Suppl 4):30-6. PubMed ID: 12102578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoprevention of nonmelanoma skin cancer.
    Soltani-Arabshahi R; Tristani-Firouzi P
    Facial Plast Surg; 2013 Oct; 29(5):373-83. PubMed ID: 24037930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COX-2, NSAIDs and human neoplasia. Part I: Colorectal neoplasms.
    Nasir A; Fernandez PM; Chughtai OR; Kaiser HE
    In Vivo; 2002; 16(6):501-9. PubMed ID: 12494894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.